Drugs / DS-5670a
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04821674 | Mar → Aug 2021 | COVID-19 | Daiichi Sankyo | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DS-5670a | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04821674 ↗ |
| Modality | Vaccine | “DS-5670a (COVID-19 Vaccine)” NCT04821674 ↗ |